These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 19830740

  • 1. Soluble HLA-I-mediated secretion of TGF-beta1 by human NK cells and consequent down-regulation of anti-tumor cytolytic activity.
    Ghio M, Contini P, Negrini S, Boero S, Musso A, Poggi A.
    Eur J Immunol; 2009 Dec; 39(12):3459-68. PubMed ID: 19830740
    [Abstract] [Full Text] [Related]

  • 2. IFN-gamma production in human NK cells through the engagement of CD8 by soluble or surface HLA class I molecules.
    Spaggiari GM, Contini P, Negrini S, Dondero A, Carosio R, Ghio M, Puppo F, Indiveri F, Zocchi MR, Poggi A.
    Eur J Immunol; 2003 Nov; 33(11):3049-59. PubMed ID: 14579273
    [Abstract] [Full Text] [Related]

  • 3. Regulation of gammadelta T cell survival by soluble HLA-I: involvement of CD8 and activating killer Ig-like receptors.
    Poggi A, Contini P, Catellani S, Setti M, Murdaca G, Zocchi MR.
    Eur J Immunol; 2005 Sep; 35(9):2670-8. PubMed ID: 16114098
    [Abstract] [Full Text] [Related]

  • 4. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
    Guo KY, Mei JZ, Yao KT.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
    [Abstract] [Full Text] [Related]

  • 5. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
    Contini P, Ghio M, Poggi A, Filaci G, Indiveri F, Ferrone S, Puppo F.
    Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
    [Abstract] [Full Text] [Related]

  • 6. B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.
    Borgerding A, Hasenkamp J, Engelke M, Burkhart N, Trümper L, Wienands J, Glass B.
    Exp Hematol; 2010 Mar; 38(3):213-21. PubMed ID: 20056126
    [Abstract] [Full Text] [Related]

  • 7. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.
    Winter CC, Gumperz JE, Parham P, Long EO, Wagtmann N.
    J Immunol; 1998 Jul 15; 161(2):571-7. PubMed ID: 9670929
    [Abstract] [Full Text] [Related]

  • 8. Cyclosporin A regulates human NK cell apoptosis induced by soluble HLA-I or by target cells.
    Poggi A, Zocchi MR.
    Autoimmun Rev; 2005 Nov 15; 4(8):532-6. PubMed ID: 16214091
    [Abstract] [Full Text] [Related]

  • 9. [Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells].
    Mei JZ, Guo KY, Wei HM, Song CY.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun 15; 27(6):887-9. PubMed ID: 17584663
    [Abstract] [Full Text] [Related]

  • 10. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals.
    Foley B, De Santis D, Lathbury L, Christiansen F, Witt C.
    Int Immunol; 2008 Apr 15; 20(4):555-63. PubMed ID: 18308713
    [Abstract] [Full Text] [Related]

  • 11. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.
    Kopp HG, Placke T, Salih HR.
    Cancer Res; 2009 Oct 01; 69(19):7775-83. PubMed ID: 19738039
    [Abstract] [Full Text] [Related]

  • 12. Soluble HLA-G promotes Th1-type cytokine production by cytokine-activated uterine and peripheral natural killer cells.
    van der Meer A, Lukassen HG, van Cranenbroek B, Weiss EH, Braat DD, van Lierop MJ, Joosten I.
    Mol Hum Reprod; 2007 Feb 01; 13(2):123-33. PubMed ID: 17121749
    [Abstract] [Full Text] [Related]

  • 13. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M, Vitale M, Carlomagno S, Ferlazzo G, Moretta L, Moretta A.
    Eur J Immunol; 2003 Jun 01; 33(6):1657-66. PubMed ID: 12778484
    [Abstract] [Full Text] [Related]

  • 14. A study of soluble HLA-G1 protecting porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
    Zeng MH, Fang CY, Wang SS, Zhu M, Xie L, Li R, Wang L, Wu XW, Chen S.
    Transplant Proc; 2006 Dec 01; 38(10):3312-4. PubMed ID: 17175258
    [Abstract] [Full Text] [Related]

  • 15. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
    Bakker AB, Phillips JH, Figdor CG, Lanier LL.
    J Immunol; 1998 Jun 01; 160(11):5239-45. PubMed ID: 9605119
    [Abstract] [Full Text] [Related]

  • 16. Natural killer cell recognition of HLA class I molecules.
    Brooks AG, Boyington JC, Sun PD.
    Rev Immunogenet; 2000 Jun 01; 2(3):433-48. PubMed ID: 11256749
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
    Zhang C, Zhang J, Niu J, Zhou Z, Zhang J, Tian Z.
    Hum Immunol; 2008 Aug 01; 69(8):490-500. PubMed ID: 18619507
    [Abstract] [Full Text] [Related]

  • 18. Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta.
    Eriksson M, Meadows SK, Wira CR, Sentman CL.
    J Leukoc Biol; 2004 Sep 01; 76(3):667-75. PubMed ID: 15178706
    [Abstract] [Full Text] [Related]

  • 19. IL-2/IL-18 prevent the down-modulation of NKG2D by TGF-beta in NK cells via the c-Jun N-terminal kinase (JNK) pathway.
    Song H, Hur DY, Kim KE, Park H, Kim T, Kim CW, Bang S, Cho DH.
    Cell Immunol; 2006 Jul 01; 242(1):39-45. PubMed ID: 17070508
    [Abstract] [Full Text] [Related]

  • 20. Natural killer clones recognize specific soluble HLA class I molecules.
    Carbone E, Terrazzano G, Colonna M, Tuosto L, Piccolella E, Franksson L, Palazzolo G, Pérez-Villar JJ, Fontana S, Kärre K, Zappacosta S.
    Eur J Immunol; 1996 Mar 01; 26(3):683-9. PubMed ID: 8605938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.